Latka logo
METiS Therapeutics logo

METiS Therapeuticsrevenue & acquisition

Clinical Research SoftwareCambridge, Massachusetts

METiS Therapeutics was acquired.

METiS, founded by a team of MIT researchers, serial entrepreneurs, and biotech industry veterans, develops and in-licenses novel assets with high therapeutic potential to leverage its data-driven platform for advancements in the field.

metistx.comLinkedInUpdated Oct 5, 2026
Annual revenue
$3.7M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
38
Dec 2023EST

METiS Therapeutics revenue

METiS Therapeutics has not published its revenue. Growjo puts it at about $3.7M a year (December 2023).

$0
$1M
$2M
$3M
$3.7M
2023
ReportedEstimateEvery reading has its own bar
As ofRevenueSource
Dec 2023$3.7MESTGrowjo estimate

Who owns METiS Therapeutics

Another company owns METiS Therapeutics. The date and price of the deal are not on record.

METiS Therapeutics CEO, founders & employees

Wenshou Wang founded METiS Therapeutics and led it as CEO. METiS Therapeutics had 38 employees (December 2023, Growjo estimate).

0
10
20
30
32
38
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 202338ESTGrowjo estimate
Dec 202232ESTGrowjo estimate

METiS Therapeutics FAQ

What was METiS Therapeutics' revenue?

Growjo estimates METiS Therapeutics' revenue at about $3.7M a year (December 2023). The company hasn't published its own figure.

How many employees does METiS Therapeutics have?

Growjo estimates METiS Therapeutics' headcount at about 38 (December 2023).

Who founded METiS Therapeutics?

Wenshou Wang founded METiS Therapeutics.

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun METiS Therapeutics? Join the podcast